The DOI matches its Crossref record; 500 of the 500 references it cites were found in a registry or an index.
Alternative splicing and related RNA binding proteins in human health and disease
Open accessAbstract
Alternative splicing (AS) serves as a pivotal mechanism in transcriptional regulation, engendering transcript diversity, and modifications in protein structure and functionality. Across varying tissues, developmental stages, or under specific conditions, AS gives rise to distinct splice isoforms. This implies that these isoforms possess unique temporal and spatial roles, thereby associating AS with standard biological activities and diseases. Among these, AS-related RNA-binding proteins (RBPs) play an instrumental role in regulating alternative splicing events. Under physiological conditions, the diversity of proteins mediated by AS influences the structure, function, interaction, and localization of proteins, thereby participating in the differentiation and development of an array of tissues and organs. Under pathological conditions, alterations in AS are linked with various diseases, particularly cancer. These changes can lead to modifications in gene splicing patterns, culminating in changes or loss of protein functionality. For instance, in cancer, abnormalities in AS and RBPs may result in aberrant expression of cancer-associated genes, thereby promoting the onset and progression of tumors. AS and RBPs are also associated with numerous neurodegenerative diseases and autoimmune diseases. Consequently, the study of AS across different tissues holds significant value. This review provides a detailed account of the recent advancements in the study of alternative splicing and AS-related RNA-binding proteins in tissue development and diseases, which aids in deepening the understanding of gene expression complexity and offers new insights and methodologies for precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712 · cited 1×
“271 Metastasis of GC is another signi fi cant factor contributing to poor patient prognosis, 272 with AS playing a crucial role.”
BackgroundGlobal aetiology and epidemiology of type 2 diabetes mellitus and its complications
Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697
Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040 · cited 1×
“250 This led to increased phosphorylation of SRPK1 and SRSFs and induced anti-apoptotic variants of some genes involved in cell apoptosis.”
BackgroundCore Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Cancer statistics in China and United States, 2022: profiles, trends, and determinants
Xia, C., Dong, X., Li, H., Cao, M., Sun, D., He, S., Yang, F., Yan, X., Zhang, S., Li, N., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002108 · Cited by 3,402
Predicting splicing from primary sequence with deep learning
Jaganathan, K., Kyriazopoulou Panagiotopoulou, S., McRae, J. F., Darbandi, S. F., Knowles, D., Li, Y. I., Kosmicki, J. A., Arbelaez, J., Cui, W., Schwartz, G. B., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.015 · Cited by 2,853
The Spliceosome: Design Principles of a Dynamic RNP Machine
Wahl, M. C., Will, C. L., & Lührmann, R. (2009) · Cell · doi:10.1016/j.cell.2009.02.009 · Cited by 2,665
Global colorectal cancer burden in 2020 and projections to 2040
Xi, Y., & Xu, P. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101174 · Cited by 2,434
Tracking the Evolution of Non–Small-Cell Lung Cancer
Jamal-Hanjani, M., Wilson, G. A., McGranahan, N., Birkbak, N. J., Watkins, T. B. K., Veeriah, S., Shafi, S., Johnson, D. H., Mitter, R., Rosenthal, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616288 · Cited by 2,349
Harbeck, N., & Gnant, M. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31891-8 · Cited by 2,280
Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Younossi, Z., Tacke, F., Arrese, M., Chander Sharma, B., Mostafa, I., Bugianesi, E., Wai‐Sun Wong, V., Yilmaz, Y., George, J., Fan, J., et al. (2019) · Hepatology · doi:10.1002/hep.30251 · Cited by 1,858 · cited 1×
“429 Many studies have pointed out that AS and AS-related RBPs play an important role in the development of NAFLD.”
BackgroundA brave new world of RNA-binding proteins
Hentze, M. W., Castello, A., Schwarzl, T., & Preiss, T. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.130 · Cited by 1,821
Molecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805
Comparative Analysis of Single-Cell RNA Sequencing Methods
Ziegenhain, C., Vieth, B., Parekh, S., Reinius, B., Guillaumet-Adkins, A., Smets, M., Leonhardt, H., Heyn, H., Hellmann, I., & Enard, W. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.01.023 · Cited by 1,494
Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP)
Van Nostrand, E. L., Pratt, G. A., Shishkin, A. A., Gelboin-Burkhart, C., Fang, M. Y., Sundararaman, B., Blue, S. M., Nguyen, T. B., Surka, C., Elkins, K., et al. (2016) · Nature Methods · doi:10.1038/nmeth.3810 · Cited by 1,397
Biffi, G., Oni, T. E., Spielman, B., Hao, Y., Elyada, E., Park, Y., Preall, J., & Tuveson, D. A. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0710 · Cited by 1,360
A large-scale binding and functional map of human RNA-binding proteins
Van Nostrand, E. L., Freese, P., Pratt, G. A., Wang, X., Wei, X., Xiao, R., Blue, S. M., Chen, J.-Y., Cody, N. A. L., Dominguez, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2077-3 · Cited by 1,317
‘Acute myeloid leukemia: a comprehensive review and 2016 update’
De Kouchkovsky, I., & Abdul-Hay, M. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.50 · Cited by 1,317
Sotillo, E., Barrett, D. M., Black, K. L., Bagashev, A., Oldridge, D., Wu, G., Sussman, R., Lanauze, C., Ruella, M., Gazzara, M. R., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1020 · Cited by 1,254
Progress and potential in organoid research
Rossi, G., Manfrin, A., & Lutolf, M. P. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0051-9 · Cited by 1,182
Alternative polyadenylation of mRNA precursors
Tian, B., & Manley, J. L. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.116 · Cited by 1,179
Scotti, M. M., & Swanson, M. S. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2015.3 · Cited by 1,163
The hnRNP family: insights into their role in health and disease
Geuens, T., Bouhy, D., & Timmerman, V. (2016) · Human Genetics · doi:10.1007/s00439-016-1683-5 · Cited by 1,093
Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,090
A day in the life of the spliceosome
Matera, A. G., & Wang, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3742 · Cited by 1,074
Context-dependent control of alternative splicing by RNA-binding proteins
Fu, X.-D., & Ares, M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3778 · Cited by 1,044
Emerging roles of E2Fs in cancer: an exit from cell cycle control
Chen, H.-Z., Tsai, S.-Y., & Leone, G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2696 · Cited by 1,021
Shen, D.-W., Pouliot, L. M., Hall, M. D., & Gottesman, M. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005637 · Cited by 955
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Schmitz, R., Young, R. M., Ceribelli, M., Jhavar, S., Xiao, W., Zhang, M., Wright, G., Shaffer, A. L., Hodson, D. J., Buras, E., et al. (2012) · Nature · doi:10.1038/nature11378 · Cited by 924
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Kahles, A., Lehmann, K.-V., Toussaint, N. C., Hüser, M., Stark, S. G., Sachsenberg, T., Stegle, O., Kohlbacher, O., Sander, C., Caesar-Johnson, S. J., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.07.001 · Cited by 897
Endocrine-responsive breast cancer and strategies for combating resistance
Ali, S., & Coombes, R. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc721 · Cited by 883
Victora, G. D., & Nussenzweig, M. C. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-120419-022408 · Cited by 824
Alternative Splicing Regulatory Networks: Functions, Mechanisms, and Evolution
Ule, J., & Blencowe, B. J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.017 · Cited by 780
EGF receptor trafficking: consequences for signaling and cancer
Tomas, A., Futter, C. E., & Eden, E. R. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.11.002 · Cited by 779
RNA-Binding Proteins in Cancer: Old Players and New Actors
Pereira, B., Billaud, M., & Almeida, R. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.05.003 · Cited by 773
Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15
Han, T., Goralski, M., Gaskill, N., Capota, E., Kim, J., Ting, T. C., Xie, Y., Williams, N. S., & Nijhawan, D. (2017) · Science · doi:10.1126/science.aal3755 · Cited by 762
Ardui, S., Ameur, A., Vermeesch, J. R., & Hestand, M. S. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky066 · Cited by 739
Roles and mechanisms of alternative splicing in cancer — implications for care
Bonnal, S. C., López-Oreja, I., & Valcárcel, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0350-x · Cited by 731
RNA Splicing by the Spliceosome
Wilkinson, M. E., Charenton, C., & Nagai, K. (2020) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-091719-064225 · Cited by 718
The immunological and metabolic landscape in primary and metastatic liver cancer
Li, X., Ramadori, P., Pfister, D., Seehawer, M., Zender, L., & Heikenwalder, M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00383-9 · Cited by 616
Neumann, M., Kwong, L. K., Lee, E. B., Kremmer, E., Flatley, A., Xu, Y., Forman, M. S., Troost, D., Kretzschmar, H. A., Trojanowski, J. Q., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0477-9 · Cited by 604
Advances in COVID-19 mRNA vaccine development
Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601
McCartney, C. R., & Marshall, J. C. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1514916 · Cited by 581
ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 Splicing
Warzecha, C. C., Sato, T. K., Nabet, B., Hogenesch, J. B., & Carstens, R. P. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.025 · Cited by 579
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
Orlando, E. J., Han, X., Tribouley, C., Wood, P. A., Leary, R. J., Riester, M., Levine, J. E., Qayed, M., Grupp, S. A., Boyer, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0146-z · Cited by 575
Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation
Florian, M. C., Dörr, K., Niebel, A., Daria, D., Schrezenmeier, H., Rojewski, M., Filippi, M.-D., Hasenberg, A., Gunzer, M., Scharffetter-Kochanek, K., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.04.007 · Cited by 564 · cited 1×
“298 Furthermore, the activation of the Rho family GTP-binding protein, Cdc42 leads to hematopoietic defects in HSPCs expressing TRAF6.”
BackgroundA postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart
Kalsotra, A., Xiao, X., Ward, A. J., Castle, J. C., Johnson, J. M., Burge, C. B., & Cooper, T. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809045105 · Cited by 508 · cited 1×
“72 In this part, we provide a summary of current knowledge on tissue development regulated by AS-related RBPs (Fig.”
BackgroundSeiler, M., Yoshimi, A., Darman, R., Chan, B., Keaney, G., Thomas, M., Agrawal, A. A., Caleb, B., Csibi, A., Sean, E., et al. (2018) · Nature Medicine · doi:10.1038/nm.4493 · Cited by 507
The physiology of alternative splicing
Marasco, L. E., & Kornblihtt, A. R. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00545-z · Cited by 505
High-risk prostate cancer—classification and therapy
Chang, A. J., Autio, K. A., Roach, M., & Scher, H. I. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.68 · Cited by 500
Alternative splicing and cancer: a systematic review
Zhang, Y., Qian, J., Gu, C., & Yang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00486-7 · Cited by 497
Reversing a model of Parkinson's disease with in situ converted nigral neurons
Qian, H., Kang, X., Hu, J., Zhang, D., Liang, Z., Meng, F., Zhang, X., Xue, Y., Maimon, R., Dowdy, S. F., et al. (2020) · Nature · doi:10.1038/s41586-020-2388-4 · Cited by 480
Lin28: Primal Regulator of Growth and Metabolism in Stem Cells
Shyh-Chang, N., & Daley, G. Q. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.03.005 · Cited by 458
Yuan, S., Norgard, R. J., & Stanger, B. Z. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0015 · Cited by 455
Alternative splicing as a source of phenotypic diversity
Wright, C. J., Smith, C. W. J., & Jiggins, C. D. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00514-4 · Cited by 454
mRNA vaccine: a potential therapeutic strategy
Wang, Y., Zhang, Z., Luo, J., Han, X., Wei, Y., & Wei, X. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01311-z · Cited by 422
Single-cell RNA-seq uncovers dynamic processes and critical regulators in mouse spermatogenesis
Chen, Y., Zheng, Y., Gao, Y., Lin, Z., Yang, S., Wang, T., Wang, Q., Xie, N., Hua, R., Liu, M., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0074-y · Cited by 420
The Apoptosis Paradox in Cancer
Morana, O., Wood, W., & Gregory, C. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031328 · Cited by 420
Lambert, N., Robertson, A., Jangi, M., McGeary, S., Sharp, P. A., & Burge, C. B. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.016 · Cited by 400
Urbanski, L. M., Leclair, N., & Anczuków, O. (2018) · WIREs RNA · doi:10.1002/wrna.1476 · Cited by 389
Regulation of Co-transcriptional Pre-mRNA Splicing by m6A through the Low-Complexity Protein hnRNPG
Zhou, K. I., Shi, H., Lyu, R., Wylder, A. C., Matuszek, Ż., Pan, J. N., He, C., Parisien, M., & Pan, T. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.005 · Cited by 382
MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis
Koh, C. M., Bezzi, M., Low, D. H. P., Ang, W. X., Teo, S. X., Gay, F. P. H., Al-Haddawi, M., Tan, S. Y., Osato, M., Sabò, A., et al. (2015) · Nature · doi:10.1038/nature14351 · Cited by 380
RNA-binding proteins in tumor progression
Qin, H., Ni, H., Liu, Y., Yuan, Y., Xi, T., Li, X., & Zheng, L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00927-w · Cited by 375
Fumagalli, S., Totty, N. F., Hsuan, J. J., & Courtneidge, S. A. (1994) · Nature · doi:10.1038/368871a0 · Cited by 363
Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex
Zhang, X., Chen, M. H., Wu, X., Kodani, A., Fan, J., Doan, R., Ozawa, M., Ma, J., Yoshida, N., Reiter, J. F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.025 · Cited by 351
RNA catalyses nuclear pre-mRNA splicing
Fica, S. M., Tuttle, N., Novak, T., Li, N.-S., Lu, J., Koodathingal, P., Dai, Q., Staley, J. P., & Piccirilli, J. A. (2013) · Nature · doi:10.1038/nature12734 · Cited by 349
Lee, S. C.-W., Dvinge, H., Kim, E., Cho, H., Micol, J.-B., Chung, Y. R., Durham, B. H., Yoshimi, A., Kim, Y. J., Thomas, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4097 · Cited by 347
Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia
Wang, E., Lu, S. X., Pastore, A., Chen, X., Imig, J., Chun-Wei Lee, S., Hockemeyer, K., Ghebrechristos, Y. E., Yoshimi, A., Inoue, D., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.010 · Cited by 338
Tabrizi, S. J., Estevez-Fraga, C., van Roon-Mom, W. M. C., Flower, M. D., Scahill, R. I., Wild, E. J., Muñoz-Sanjuan, I., Sampaio, C., Rosser, A. E., & Leavitt, B. R. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00121-1 · Cited by 331
Mechanisms of the androgen receptor splicing in prostate cancer cells
Liu, L. L., Xie, N., Sun, S., Plymate, S., Mostaghel, E., & Dong, X. (2014) · Oncogene · doi:10.1038/onc.2013.284 · Cited by 315
The Potential of MicroRNAs as Prostate Cancer Biomarkers
Fabris, L., Ceder, Y., Chinnaiyan, A. M., Jenster, G. W., Sorensen, K. D., Tomlins, S., Visakorpi, T., & Calin, G. A. (2016) · European Urology · doi:10.1016/j.eururo.2015.12.054 · Cited by 311
The role of alternative splicing in cancer: From oncogenesis to drug resistance
Sciarrillo, R., Wojtuszkiewicz, A., Assaraf, Y. G., Jansen, G., Kaspers, G. J. L., Giovannetti, E., & Cloos, J. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100728 · Cited by 307
The RNA-Binding Protein NANOS2 Is Required to Maintain Murine Spermatogonial Stem Cells
Sada, A., Suzuki, A., Suzuki, H., & Saga, Y. (2009) · Science · doi:10.1126/science.1172645 · Cited by 305
Erratum: New frontiers in translational control of the cancer genome
Truitt, M. L., & Ruggero, D. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.30 · Cited by 303
Advances in CLIP Technologies for Studies of Protein-RNA Interactions
Lee, F. C. Y., & Ule, J. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.005 · Cited by 296
Specificity and nonspecificity in RNA–protein interactions
Jankowsky, E., & Harris, M. E. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4032 · Cited by 283
An Atomic Structure of the Human Spliceosome
Zhang, X., Yan, C., Hang, J., Finci, L. I., Lei, J., & Shi, Y. (2017) · Cell · doi:10.1016/j.cell.2017.04.033 · Cited by 269
Cryo-EM Structure of a Pre-catalytic Human Spliceosome Primed for Activation
Bertram, K., Agafonov, D. E., Dybkov, O., Haselbach, D., Leelaram, M. N., Will, C. L., Urlaub, H., Kastner, B., Lührmann, R., & Stark, H. (2017) · Cell · doi:10.1016/j.cell.2017.07.011 · Cited by 265
Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets
Kudinov, A. E., Karanicolas, J., Golemis, E. A., & Boumber, Y. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2728 · Cited by 262
Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer
Kędzierska, H., & Piekiełko-Witkowska, A. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.013 · Cited by 262
Zhou, L., Azfer, A., Niu, J., Graham, S., Choudhury, M., Adamski, F. M., Younce, C., Binkley, P. F., & Kolattukudy, P. E. (2006) · Circulation Research · doi:10.1161/01.res.0000220106.64661.71 · Cited by 260
The bone microenvironment invigorates metastatic seeds for further dissemination
Zhang, W., Bado, I. L., Hu, J., Wan, Y.-W., Wu, L., Wang, H., Gao, Y., Jeong, H.-H., Xu, Z., Hao, X., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.011 · Cited by 260
Self-citationFunctions and consequences of AID/APOBEC-mediated DNA and RNA deamination
Pecori, R., Di Giorgio, S., Paulo Lorenzo, J., & Nina Papavasiliou, F. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00459-8 · Cited by 253
Calabretta, S., Bielli, P., Passacantilli, I., Pilozzi, E., Fendrich, V, Capurso, G., Fave, G. D., & Sette, C. (2016) · Oncogene · doi:10.1038/onc.2015.270 · Cited by 249
Genetic control of RNA splicing and its distinct role in complex trait variation
Qi, T., Wu, Y., Fang, H., Zhang, F., Liu, S., Zeng, J., & Yang, J. (2022) · Nature Genetics · doi:10.1038/s41588-022-01154-4 · Cited by 247
Kalev, P., Hyer, M. L., Gross, S., Konteatis, Z., Chen, C.-C., Fletcher, M., Lein, M., Aguado-Fraile, E., Frank, V., Barnett, A., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.12.010 · Cited by 243
Huang, Y., Kan, M., Lin, C., & Richter, J. D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601322 · Cited by 236
Regulation of adult stem cell quiescence and its functions in the maintenance of tissue integrity
de Morree, A., & Rando, T. A. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00568-6 · Cited by 235
Golan-Gerstl, R., Cohen, M., Shilo, A., Suh, S.-S., Bakàcs, A., Coppola, L., & Karni, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4410 · Cited by 232
VICKZ proteins: a multi‐talented family of regulatory RNA‐binding proteins
Yisraeli, J. K. (2005) · Biology of the Cell · doi:10.1042/bc20040151 · Cited by 231
Spliceosomal disruption of the non-canonical BAF complex in cancer
Inoue, D., Chew, G.-L., Liu, B., Michel, B. C., Pangallo, J., D’Avino, A. R., Hitchman, T., North, K., Lee, S. C.-W., Bitner, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1646-9 · Cited by 229
Erkelenz, S., Mueller, W. F., Evans, M. S., Busch, A., Schöneweis, K., Hertel, K. J., & Schaal, H. (2013) · RNA · doi:10.1261/rna.037044.112 · Cited by 224
Chromatin Remodeling BAF (SWI/SNF) Complexes in Neural Development and Disorders
Sokpor, G., Xie, Y., Rosenbusch, J., & Tuoc, T. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00243 · Cited by 224
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer
Bowling, E. A., Wang, J. H., Gong, F., Wu, W., Neill, N. J., Kim, I. S., Tyagi, S., Orellana, M., Kurley, S. J., Dominguez-Vidaña, R., et al. (2021) · Cell · doi:10.1016/j.cell.2020.12.031 · Cited by 224
Datta, A., Kim, H., Lal, M., McGee, L., Johnson, A., Moustafa, A. A., Jones, J. C., Mondal, D., Ferrer, M., & Abdel-Mageed, A. B. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.020 · Cited by 222
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis
Yoshimi, A., Lin, K.-T., Wiseman, D. H., Rahman, M. A., Pastore, A., Wang, B., Lee, S. C.-W., Micol, J.-B., Zhang, X. J., de Botton, S., et al. (2019) · Nature · doi:10.1038/s41586-019-1618-0 · Cited by 220
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations
Lee, S. C.-W., North, K., Kim, E., Jang, E., Obeng, E., Lu, S. X., Liu, B., Inoue, D., Yoshimi, A., Ki, M., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.07.003 · Cited by 219
Mcl-1 Is Essential for Germinal Center Formation and B Cell Memory
Vikstrom, I., Carotta, S., Lüthje, K., Peperzak, V., Jost, P. J., Glaser, S., Busslinger, M., Bouillet, P., Strasser, A., Nutt, S. L., et al. (2010) · Science · doi:10.1126/science.1191793 · Cited by 215
Rbfox Proteins Regulate Splicing as Part of a Large Multiprotein Complex LASR
Damianov, A., Ying, Y., Lin, C.-H., Lee, J.-A., Tran, D., Vashisht, A. A., Bahrami-Samani, E., Xing, Y., Martin, K. C., Wohlschlegel, J. A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.03.040 · Cited by 211
Braun, C. J., Stanciu, M., Boutz, P. L., Patterson, J. C., Calligaris, D., Higuchi, F., Neupane, R., Fenoglio, S., Cahill, D. P., Wakimoto, H., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.018 · Cited by 208
Zhou, H.-L., Luo, G., Wise, J. A., & Lou, H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt875 · Cited by 207
Zhang, F., Wang, H., Yu, J., Yao, X., Yang, S., Li, W., Xu, L., & Zhao, L. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01299-y · Cited by 205
Self-citationCheng, C. Y., Wong, E. W. P., Yan, H. H. N., & Mruk, D. D. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.004 · Cited by 202
Pullmann, R., Kim, H. H., Abdelmohsen, K., Lal, A., Martindale, J. L., Yang, X., & Gorospe, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00500-07 · Cited by 199 · cited 1×
“33 However, the regulation of such regulation is not yet clear.”
BackgroundSelf-citationA Structural Model of the Endogenous Human BAF Complex Informs Disease Mechanisms
Mashtalir, N., Suzuki, H., Farrell, D. P., Sankar, A., Luo, J., Filipovski, M., D’Avino, A. R., St. Pierre, R., Valencia, A. M., Onikubo, T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.051 · Cited by 198
BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells
Zhou, X., Li, X., Cheng, Y., Wu, W., Xie, Z., Xi, Q., Han, J., Wu, G., Fang, J., & Feng, Y. (2014) · Nature Communications · doi:10.1038/ncomms5581 · Cited by 194
Genetics and prognosis of ALL in children vs adults
Roberts, K. G. (2018) · Hematology · doi:10.1182/asheducation-2018.1.137 · Cited by 194
Licatalosi, D. D., Yano, M., Fak, J. J., Mele, A., Grabinski, S. E., Zhang, C., & Darnell, R. B. (2012) · Genes & Development · doi:10.1101/gad.191338.112 · Cited by 193
Li, W.-J., He, Y.-H., Yang, J.-J., Hu, G.-S., Lin, Y.-A., Ran, T., Peng, B.-L., Xie, B.-L., Huang, M.-F., Gao, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21963-1 · Cited by 191
Alternative splicing in prostate cancer
Paschalis, A., Sharp, A., Welti, J. C., Neeb, A., Raj, G. V., Luo, J., Plymate, S. R., & de Bono, J. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0085-0 · Cited by 190
Alternative splicing in neurodegenerative disease and the promise of RNA therapies
Nikom, D., & Zheng, S. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00717-6 · Cited by 190
QKI shuttles internal m7G-modified transcripts into stress granules and modulates mRNA metabolism
Zhao, Z., Qing, Y., Dong, L., Han, L., Wu, D., Li, Y., Li, W., Xue, J., Zhou, K., Sun, M., et al. (2023) · Cell · doi:10.1016/j.cell.2023.05.047 · Cited by 188
Wan, L., Yu, W., Shen, E., Sun, W., Liu, Y., Kong, J., Wu, Y., Han, F., Zhang, L., Yu, T., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-314983 · Cited by 187
Wang, H., Liang, L., Dong, Q., Huan, L., He, J., Li, B., Yang, C., Jin, H., Wei, L., Yu, C., et al. (2018) · Theranostics · doi:10.7150/thno.23012 · Cited by 186
Self-citationNew connections between splicing and human disease
Padgett, R. A. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.01.001 · Cited by 185
Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous System
Martinez, F. J., Pratt, G. A., Van Nostrand, E. L., Batra, R., Huelga, S. C., Kapeli, K., Freese, P., Chun, S. J., Ling, K., Gelboin-Burkhart, C., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.050 · Cited by 185
Self-citationWang, X., Li, J., Bian, X., Wu, C., Hua, J., Chang, S., Yu, T., Li, H., Li, Y., Hu, S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012881118 · Cited by 184
The changing paradigm of intron retention: regulation, ramifications and recipes
Monteuuis, G., Wong, J. J. L., Bailey, C. G., Schmitz, U., & Rasko, J. E. J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1068 · Cited by 182
Targeting mRNA processing as an anticancer strategy
Desterro, J., Bak-Gordon, P., & Carmo-Fonseca, M. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0042-3 · Cited by 181
Medical management of gastric cancer: a 2017 update
Charalampakis, N., Economopoulou, P., Kotsantis, I., Tolia, M., Schizas, D., Liakakos, T., Elimova, E., Ajani, J. A., & Psyrri, A. (2018) · Cancer Medicine · doi:10.1002/cam4.1274 · Cited by 179
DNA repair processes are critical mediators of p53-dependent tumor suppression
Janic, A., Valente, L. J., Wakefield, M. J., Di Stefano, L., Milla, L., Wilcox, S., Yang, H., Tai, L., Vandenberg, C. J., Kueh, A. J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0043-5 · Cited by 179
Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B
Zhou, X., Wang, R., Li, X., Yu, L., Hua, D., Sun, C., Shi, C., Luo, W., Rao, C., Jiang, Z., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120279 · Cited by 179
Decorsière, A., Cayrel, A., Vagner, S., & Millevoi, S. (2011) · Genes & Development · doi:10.1101/gad.607011 · Cited by 177
Evolutionary functional analysis and molecular regulation of the ZEB transcription factors
Gheldof, A., Hulpiau, P., van Roy, F., De Craene, B., & Berx, G. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0935-3 · Cited by 177
Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response
Huan, L., Guo, T., Wu, Y., Xu, L., Huang, S., Xu, Y., Liang, L., & He, X. (2020) · Molecular Cancer · doi:10.1186/s12943-019-1122-z · Cited by 177
SRSF2 Regulates Alternative Splicing to Drive Hepatocellular Carcinoma Development
Luo, C., Cheng, Y., Liu, Y., Chen, L., Liu, L., Wei, N., Xie, Z., Wu, W., & Feng, Y. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1919 · Cited by 176
Venables, J. P., Brosseau, J., Gadéa, G., Klinck, R., Prinos, P., Beaulieu, J., Lapointe, E., Durand, M., Thibault, P., Tremblay, K., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01174-12 · Cited by 174
PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia
Radzisheuskaya, A., Shliaha, P. V., Grinev, V., Lorenzini, E., Kovalchuk, S., Shlyueva, D., Gorshkov, V., Hendrickson, R. C., Jensen, O. N., & Helin, K. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0313-z · Cited by 172
The U1 spliceosomal RNA is recurrently mutated in multiple cancers
Shuai, S., Suzuki, H., Diaz-Navarro, A., Nadeu, F., Kumar, S. A., Gutierrez-Fernandez, A., Delgado, J., Pinyol, M., López-Otín, C., Puente, X. S., et al. (2019) · Nature · doi:10.1038/s41586-019-1651-z · Cited by 171
The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function
Alexander, D. R. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0218 · Cited by 170
RNA-binding proteins and cancer metastasis
Wang, S., Sun, Z., Lei, Z., & Zhang, H.-T. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.018 · Cited by 169
The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation
Gu, X., Nardone, C., Kamitaki, N., Mao, A., Elledge, S. J., & Greenberg, M. E. (2023) · Science · doi:10.1126/science.adh5021 · Cited by 169
Lantz, V., Ambrosio, L., & Schedl, P. (1992) · Development · doi:10.1242/dev.115.1.75 · Cited by 168
RBM24 Is a Major Regulator of Muscle-Specific Alternative Splicing
Yang, J., Hung, L.-H., Licht, T., Kostin, S., Looso, M., Khrameeva, E., Bindereif, A., Schneider, A., & Braun, T. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.08.025 · Cited by 168
How Is Precursor Messenger RNA Spliced by the Spliceosome?
Wan, R., Bai, R., Zhan, X., & Shi, Y. (2020) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111024 · Cited by 168
The CPEB-family of proteins, translational control in senescence and cancer
Fernández‐Miranda, G., & Méndez, R. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.03.004 · Cited by 167
Zhou, L., Jiang, J., Huang, Z., Jin, P., Peng, L., Luo, M., Zhang, Z., Chen, Y., Xie, N., Gao, W., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01638-1 · Cited by 167
c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment
Gao, F.-Y., Li, X.-T., Xu, K., Wang, R.-T., & Guan, X.-X. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01043-1 · Cited by 167
Splicing factor SRSF3 is crucial for hepatocyte differentiation and metabolic function
Sen, S., Jumaa, H., & Webster, N. J. G. (2013) · Nature Communications · doi:10.1038/ncomms2342 · Cited by 166
Alternative splicing and cell survival: from tissue homeostasis to disease
Paronetto, M. P., Passacantilli, I., & Sette, C. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.91 · Cited by 166
The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer
Ramesh-Kumar, D., & Guil, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.05.009 · Cited by 166
The La and related RNA ‐binding proteins (LARPs): structures, functions, and evolving perspectives
Maraia, R. J., Mattijssen, S., Cruz‐Gallardo, I., & Conte, M. R. (2017) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1430 · Cited by 165
Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis
Zhu, W., Zhou, B., Rong, L., Li, Y., Xu, H., Zhou, Y., Yan, X., Liu, W., Zhu, B., Wang, L., et al. (2020) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1900422 · Cited by 165
ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance
Xu, Y., Huangyang, P., Wang, Y., Xue, L., Devericks, E., Nguyen, H. G., Yu, X., Oses-Prieto, J. A., Burlingame, A. L., Miglani, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.036 · Cited by 165
Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL
Zhao, Y., Aldoss, I., Qu, C., Crawford, J. C., Gu, Z., Allen, E. K., Zamora, A. E., Alexander, T. B., Wang, J., Goto, H., et al. (2021) · Blood · doi:10.1182/blood.2020006287 · Cited by 164
Pihlajamäki, J., Lerín, C., Itkonen, P., Boes, T., Floß, T., Schroeder, J., Dearie, F., Crunkhorn, S., Burak, M. F., Jiménez‐Chillarón, J. C., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.007 · Cited by 163
Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner
Liao, L., He, Y., Li, S.-J., Yu, X.-M., Liu, Z.-C., Liang, Y.-Y., Yang, H., Yang, J., Zhang, G.-G., Deng, C.-M., et al. (2023) · Cell Research · doi:10.1038/s41422-023-00793-4 · Cited by 163
Toll-like receptor alterations in myelodysplastic syndrome
Wei, Y., Dimicoli, S., Bueso-Ramos, C., Chen, R., Yang, H., Neuberg, D., Pierce, S., Jia, Y., Zheng, H., Wang, H., et al. (2013) · Leukemia · doi:10.1038/leu.2013.180 · Cited by 161
Self-citationSplicing factor hnRNPH drives an oncogenic splicing switch in gliomas
LeFave, C. V., Squatrito, M., Vorlová, S., Rocco, G., Brennan, C., Holland, E. C., Pan, Y., & Cartegni, L. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.259 · Cited by 160
Ilf3 and NF90 functions in RNA biology
Castella, S., Bernard, R., Corno, M., Fradin, A., & Larcher, J.-C. (2014) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1270 · Cited by 159
The RNA-binding protein HuR is essential for the B cell antibody response
Diaz-Muñoz, M. D., Bell, S. E., Fairfax, K., Monzon-Casanova, E., Cunningham, A. F., Gonzalez-Porta, M., Andrews, S. R., Bunik, V. I., Zarnack, K., Curk, T., et al. (2015) · Nature Immunology · doi:10.1038/ni.3115 · Cited by 159
Altered RNA Processing in Cancer Pathogenesis and Therapy
Obeng, E. A., Stewart, C., & Abdel-Wahab, O. I. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0399 · Cited by 159
Legrand, J. M. D., Chan, A.-L., La, H. M., Rossello, F. J., Änkö, M.-L., Fuller-Pace, F. V., & Hobbs, R. M. (2019) · Nature Communications · doi:10.1038/s41467-019-09972-7 · Cited by 158
Leclair, N. K., Brugiolo, M., Urbanski, L., Lawson, S. C., Thakar, K., Yurieva, M., George, J., Hinson, J. T., Cheng, A., Graveley, B. R., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.019 · Cited by 158
Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development
Quesnel-Vallières, M., Irimia, M., Cordes, S. P., & Blencowe, B. J. (2015) · Genes & Development · doi:10.1101/gad.256115.114 · Cited by 155 · cited 1×
“93 – 96 HuD and SAM68 play integral roles at various stages of neural development, suggesting that speci fi c regulatory partnerships are manipulated during distinct phases of neural development.”
BackgroundAuto-regulatory feedback by RNA-binding proteins
Müller-McNicoll, M., Roßbach, O., Hui, J., & Medenbach, J. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz043 · Cited by 155
RNA binding motif (RBM) proteins: A novel family of apoptosis modulators?
Sutherland, L. C., Rintala‐Maki, N. D., White, R. D., & Morin, C. D. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20204 · Cited by 154
Li, S., Hu, Z., Zhao, Y., Huang, S., & He, X. (2018) · Hepatology · doi:10.1002/hep.30158 · Cited by 154
Tam, B. Y. Y., Chiu, K., Chung, H., Bossard, C., Nguyen, J. D., Creger, E., Eastman, B. W., Mak, C. C., Ibanez, M., Ghias, A., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.09.009 · Cited by 154
Increase in the Incidence of Diabetes and Its Implications
Ingelfinger, J. R., & Jarcho, J. A. (2017) · New England Journal of Medicine · doi:10.1056/nejme1616575 · Cited by 152
PTBP1 and PTBP2 Serve Both Specific and Redundant Functions in Neuronal Pre-mRNA Splicing
Vuong, J. K., Lin, C.-H., Zhang, M., Chen, L., Black, D. L., & Zheng, S. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.034 · Cited by 151
Rbfox2 controls autoregulation in RNA-binding protein networks
Jangi, M., Boutz, P. L., Paul, P., & Sharp, P. A. (2014) · Genes & Development · doi:10.1101/gad.235770.113 · Cited by 148
The La-Related Proteins, a Family with Connections to Cancer
Stavraka, C., & Blagden, S. P. (2015) · Biomolecules · doi:10.3390/biom5042701 · Cited by 147
de Bruin, R. G., Shiue, L., Prins, J., de Boer, H. C., Singh, A., Fagg, W. S., van Gils, J. M., Duijs, J. M. G. J., Katzman, S. J., Kraaijeveld, A. O., et al. (2016) · Nature Communications · doi:10.1038/ncomms10846 · Cited by 145
Sun, S., Gao, T., Pang, B., Su, X., Guo, C., Zhang, R., & Pang, Q. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04524-2 · Cited by 144
Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease
de Bruin, R. G., Rabelink, T. J., van Zonneveld, A. J., & van der Veer, E. P. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw567 · Cited by 143
Alternative transcription and alternative splicing in cancer
Pal, S., Gupta, R., & Davuluri, R. V. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.005 · Cited by 142
RNA splicing analysis using heterogeneous and large RNA-seq datasets
Vaquero-Garcia, J., Aicher, J. K., Jewell, S., Gazzara, M. R., Radens, C. M., Jha, A., Green, C. J., Norton, S., Lahens, N. F., Grant, G. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36585-y · Cited by 141
Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential
Zhu, T., Hong, L., & Ling, Z. (2023) · Biomarker Research · doi:10.1186/s40364-023-00499-0 · Cited by 140
Sen, S., Langiewicz, M., Jumaa, H., & Webster, N. J. G. (2014) · Hepatology · doi:10.1002/hep.27380 · Cited by 135
van den Hoogenhof (2016) · doi:10.1161/circresaha.115.307872 · Cited by 134
Rabilloud, T., Potier, D., Pankaew, S., Nozais, M., Loosveld, M., & Payet‐Bornet, D. (2021) · Nature Communications · doi:10.1038/s41467-021-21168-6 · Cited by 134
Al-harbi, S., Aljurf, M. D., Mohty, M., Almohareb, F. I., & Ahmed, S. O. A. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000168 · Cited by 132
Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1
Zhang, J., Ali, A. M., Lieu, Y. K., Liu, Z., Gao, J., Rabadán, R., Raza, A., Mukherjee, S., & Manley, J. L. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.017 · Cited by 131
Gonatopoulos-Pournatzis, T., Wu, M., Braunschweig, U., Roth, J. F., Han, H. R., Best, A. J., Raj, B., Aregger, M., O’Hanlon, D., Ellis, J. D., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.10.008 · Cited by 130
ZEBs: Novel Players in Immune Cell Development and Function.
Scott, C., & Omilusik, K. (2019) · Trends in immunology · doi:10.1016/j.it.2019.03.001 · Cited by 129
HuR as a molecular target for cancer therapeutics and immune-related disorders
Majumder, M., Chakraborty, P., Mohan, S., Mehrotra, S., & Palanisamy, V. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114442 · Cited by 128
Shilo, A., Ben-Hur, V., Denichenko, P., Stein, I., Pikarsky, E., Rauch, J., Kölch, W., Zender, L., & Karni, R. (2014) · RNA · doi:10.1261/rna.042259.113 · Cited by 127
Ajiro, M., Jia, R., Yang, Y., Zhu, J., & Zheng, Z. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1500 · Cited by 127
Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1
Du, J.-X., Luo, Y., Zhang, S., Wang, B., Chen, C., Zhu, G., Zhu, P., Cai, C.-Z., Wan, J.-L., Cai, J., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01978-8 · Cited by 127
Lv, Y., Zhang, W., Zhao, J., Sun, B., Qi, Y., Ji, H., Chen, C., Zhang, J., Sheng, J., Wang, T., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00495-6 · Cited by 126
Pai, T.-P., Chen, C.-C., Lin, H., Chin, A., Lai, J. S.-Y., Lee, P.-T., Tully, T., & Chiang, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216336110 · Cited by 123
Aberrant hnRNP K expression: All roads lead to cancer
Gallardo, M., Aitken, M. J. L., Zhang, X., Hu, P. C., Bueso-Ramos, C., & Post, S. M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1164372 · Cited by 123
Degradation of splicing factor SRSF3 contributes to progressive liver disease
Kumar, D., Das, M., Sauceda, C., Ellies, L. G., Kuo, K., Parwal, P., Kaur, M., Jih, L., Bandyopadhyay, G. K., Burton, D. W., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127374 · Cited by 123
Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease
Ren, P., Lu, L., Cai, S., Chen, J., Lin, W., & Han, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.713540 · Cited by 123
Quaking, an RNA-Binding Protein, Is a Critical Regulator of Vascular Smooth Muscle Cell Phenotype
van der Veer, E. P., de Bruin, R. G., Kraaijeveld, A. O., de Vries, M. R., Bot, I., Pera, T., Segers, F. M., Trompet, S., van Gils, J. M., Roeten, M. K., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301302 · Cited by 122
RNA-binding proteins balance brain function in health and disease
Schieweck, R., Ninkovic, J., & Kiebler, M. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00047.2019 · Cited by 122
Mnk2 Alternative Splicing Modulates the p38-MAPK Pathway and Impacts Ras-Induced Transformation
Maimon, A., Mogilevsky, M., Shilo, A., Golan‐Gerstl, R., Obiedat, A., Ben-Hur, V., Lebenthal-Loinger, I., Stein, I., Reich, R., Beenstock, J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.041 · Cited by 121
Emerging themes in cohesin cancer biology
Waldman, T. A. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0270-1 · Cited by 121
Ratni, H., Karp, G. M., Weetall, M. L., Naryshkin, N. A., Paushkin, S. V., Chen, K. S., McCarthy, K. D., Qi, H., Turpoff, A., Woll, M. G., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00459 · Cited by 119
Hu, X., Harvey, S. E., Zheng, R., Lyu, J., Grzeskowiak, C. L., Powell, E., Piwnica-Worms, H. M., Scott, K. L., & Cheng, C. (2020) · Nature Communications · doi:10.1038/s41467-020-14304-1 · Cited by 119
Combinatorial Genetics Reveals a Scaling Law for the Effects of Mutations on Splicing
Baeza-Centurión, P., Miñana, B., Schmiedel, J. M., Valcárcel, J., & Lehner, B. (2019) · Cell · doi:10.1016/j.cell.2018.12.010 · Cited by 118
Aberrant alternative splicing in breast cancer
Yang, Q., Zhao, J., Zhang, W., Chen, D., & Wang, Y. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz033 · Cited by 117
The Role of Alternative Splicing in the Control of Immune Homeostasis and Cellular Differentiation
Yabas, M., Elliott, H., & Hoyne, G. F. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010003 · Cited by 116
Splicing Activation by Rbfox Requires Self-Aggregation through Its Tyrosine-Rich Domain
Yi, Y., Wang, X., Vuong, C. K., Lin, C.-H., Damianov, A., & Black, D. L. (2017) · Cell · doi:10.1016/j.cell.2017.06.022 · Cited by 116
Alternative splicing of the androgen receptor in polycystic ovary syndrome
Wang, F., Pan, J., Liu, Y., Meng, Q., Lv, P., Qu, F., Ding, G., Klausen, C., Leung, P. C. K., Chan, H. C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418216112 · Cited by 115
Cited by
Impact of Acute Endurance Exercise on Alternative Splicing in Skeletal Muscle
Ahn, A., Kim, J. J., Slusher, A. L., Ying, J. Y., Zhang, E. Y., & Ludlow, A. T. (2025) · FASEB BioAdvances · doi:10.1096/fba.2025-00007 · Cited by 4
Metadata
- Authors
- Tao, Y., Zhang, Q., Wang, H., Yang, X., & Mu, H.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-02-02
- Volume
- 9
- Issue
- 1
- Pages
- 26-26
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4392785459
- Cited by
- 320
- References
- 500
- FWCI
- 36.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.